Cargando…

Impaired Lipid and Glucose Homeostasis in Hexabromocyclododecane-Exposed Mice Fed a High-Fat Diet

Background: Hexabromocyclododecane (HBCD) is an additive flame retardant used in the textile industry and in polystyrene foam manufacturing. Because of its lipophilicity and persistency, HBCD accumulates in adipose tissue and thus has the potential of causing metabolic disorders through disruption o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagisawa, Rie, Koike, Eiko, Win-Shwe, Tin-Tin, Yamamoto, Megumi, Takano, Hirohisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948039/
https://www.ncbi.nlm.nih.gov/pubmed/24398136
http://dx.doi.org/10.1289/ehp.1307421
_version_ 1782306742336487424
author Yanagisawa, Rie
Koike, Eiko
Win-Shwe, Tin-Tin
Yamamoto, Megumi
Takano, Hirohisa
author_facet Yanagisawa, Rie
Koike, Eiko
Win-Shwe, Tin-Tin
Yamamoto, Megumi
Takano, Hirohisa
author_sort Yanagisawa, Rie
collection PubMed
description Background: Hexabromocyclododecane (HBCD) is an additive flame retardant used in the textile industry and in polystyrene foam manufacturing. Because of its lipophilicity and persistency, HBCD accumulates in adipose tissue and thus has the potential of causing metabolic disorders through disruption of lipid and glucose homeostasis. However, the association between HBCD and obesity remains unclear. Objectives: We investigated whether exposure to HBCD contributes to initiation and progression of obesity and related metabolic dysfunction in mice fed a normal diet (ND) or a high-fat diet (HFD). Methods: Male C57BL/6J mice were fed a HFD (62.2 kcal% fat) or a ND and treated orally with HBCD (0, 1.75, 35, or 700 μg/kg body weight) weekly from 6 to 20 weeks of age. We examined body weight, liver weight, blood biochemistry, histopathological changes, and gene expression profiles in the liver and adipose tissue. Results: In HFD-fed mice, body and liver weight were markedly increased in mice treated with the high (700 μg/kg) and medium (35 μg/kg) doses of HBCD compared with vehicle. This effect was more prominent in the high-dose group. These increases were paralleled by increases in random blood glucose and insulin levels and enhancement of microvesicular steatosis and macrophage accumulation in adipose tissue. HBCD-treated HFD-fed mice also had increased mRNA levels of Pparg (peroxisome proliferator-activated receptor-γ) in the liver and decreased mRNA levels of Glut4 (glucose transporter 4) in adipose tissue compared with vehicle-treated HFD-fed mice. Conclusions: Our findings suggest that HBCD may contribute to enhancement of diet-induced body weight gain and metabolic dysfunction through disruption of lipid and glucose homeostasis, resulting in accelerated progression of obesity. Citation: Yanagisawa R, Koike E, Win-Shwe TT, Yamamoto M, Takano H. 2014. Impaired lipid and glucose homeostasis in hexabromocyclododecane-exposed mice fed a high-fat diet. Environ Health Perspect 122:277–283; http://dx.doi.org/10.1289/ehp.1307421
format Online
Article
Text
id pubmed-3948039
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher National Institute of Environmental Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-39480392014-03-20 Impaired Lipid and Glucose Homeostasis in Hexabromocyclododecane-Exposed Mice Fed a High-Fat Diet Yanagisawa, Rie Koike, Eiko Win-Shwe, Tin-Tin Yamamoto, Megumi Takano, Hirohisa Environ Health Perspect Research Background: Hexabromocyclododecane (HBCD) is an additive flame retardant used in the textile industry and in polystyrene foam manufacturing. Because of its lipophilicity and persistency, HBCD accumulates in adipose tissue and thus has the potential of causing metabolic disorders through disruption of lipid and glucose homeostasis. However, the association between HBCD and obesity remains unclear. Objectives: We investigated whether exposure to HBCD contributes to initiation and progression of obesity and related metabolic dysfunction in mice fed a normal diet (ND) or a high-fat diet (HFD). Methods: Male C57BL/6J mice were fed a HFD (62.2 kcal% fat) or a ND and treated orally with HBCD (0, 1.75, 35, or 700 μg/kg body weight) weekly from 6 to 20 weeks of age. We examined body weight, liver weight, blood biochemistry, histopathological changes, and gene expression profiles in the liver and adipose tissue. Results: In HFD-fed mice, body and liver weight were markedly increased in mice treated with the high (700 μg/kg) and medium (35 μg/kg) doses of HBCD compared with vehicle. This effect was more prominent in the high-dose group. These increases were paralleled by increases in random blood glucose and insulin levels and enhancement of microvesicular steatosis and macrophage accumulation in adipose tissue. HBCD-treated HFD-fed mice also had increased mRNA levels of Pparg (peroxisome proliferator-activated receptor-γ) in the liver and decreased mRNA levels of Glut4 (glucose transporter 4) in adipose tissue compared with vehicle-treated HFD-fed mice. Conclusions: Our findings suggest that HBCD may contribute to enhancement of diet-induced body weight gain and metabolic dysfunction through disruption of lipid and glucose homeostasis, resulting in accelerated progression of obesity. Citation: Yanagisawa R, Koike E, Win-Shwe TT, Yamamoto M, Takano H. 2014. Impaired lipid and glucose homeostasis in hexabromocyclododecane-exposed mice fed a high-fat diet. Environ Health Perspect 122:277–283; http://dx.doi.org/10.1289/ehp.1307421 National Institute of Environmental Health Sciences 2014-01-07 2014-03 /pmc/articles/PMC3948039/ /pubmed/24398136 http://dx.doi.org/10.1289/ehp.1307421 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, “Reproduced with permission from Environmental Health Perspectives”); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Yanagisawa, Rie
Koike, Eiko
Win-Shwe, Tin-Tin
Yamamoto, Megumi
Takano, Hirohisa
Impaired Lipid and Glucose Homeostasis in Hexabromocyclododecane-Exposed Mice Fed a High-Fat Diet
title Impaired Lipid and Glucose Homeostasis in Hexabromocyclododecane-Exposed Mice Fed a High-Fat Diet
title_full Impaired Lipid and Glucose Homeostasis in Hexabromocyclododecane-Exposed Mice Fed a High-Fat Diet
title_fullStr Impaired Lipid and Glucose Homeostasis in Hexabromocyclododecane-Exposed Mice Fed a High-Fat Diet
title_full_unstemmed Impaired Lipid and Glucose Homeostasis in Hexabromocyclododecane-Exposed Mice Fed a High-Fat Diet
title_short Impaired Lipid and Glucose Homeostasis in Hexabromocyclododecane-Exposed Mice Fed a High-Fat Diet
title_sort impaired lipid and glucose homeostasis in hexabromocyclododecane-exposed mice fed a high-fat diet
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948039/
https://www.ncbi.nlm.nih.gov/pubmed/24398136
http://dx.doi.org/10.1289/ehp.1307421
work_keys_str_mv AT yanagisawarie impairedlipidandglucosehomeostasisinhexabromocyclododecaneexposedmicefedahighfatdiet
AT koikeeiko impairedlipidandglucosehomeostasisinhexabromocyclododecaneexposedmicefedahighfatdiet
AT winshwetintin impairedlipidandglucosehomeostasisinhexabromocyclododecaneexposedmicefedahighfatdiet
AT yamamotomegumi impairedlipidandglucosehomeostasisinhexabromocyclododecaneexposedmicefedahighfatdiet
AT takanohirohisa impairedlipidandglucosehomeostasisinhexabromocyclododecaneexposedmicefedahighfatdiet